广誉远最新公告：西黄丸和感冒清热颗粒中选全国中成药集采

证券之星06-18

广誉远(600771.SH)公告称，公司控股子公司山西广誉远生产的西黄丸和感冒清热颗粒两款产品首次进入集采体系，且在本次全国中成药采购联盟集中带量采购中直接中选。上述产品2025年度及2026年第一季度销售收入极低，预计本次集采中选价格不会对公司现有存量业务的毛利率及当期利润产生重大不利影响。采购周期自中选结果实际执行之日起至2028年12月31日。

以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2644079701?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-06-18 17:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2644079701","market":"sh","top_or_hot":-1,"title":"广誉远最新公告：西黄丸和感冒清热颗粒中选全国中成药集采","media":"证券之星","content":"<html><body><p><a href=\"https://laohu8.com/S/600771\">广誉远</a>(600771.SH)公告称，公司控股子公司山西广誉远生产的西黄丸和感冒清热颗粒两款产品首次进入集采体系，且在本次全国中成药采购联盟集中带量采购中直接中选。上述产品2025年度及2026年第一季度销售收入极低，预计本次集采中选价格不会对公司现有存量业务的毛利率及当期利润产生重大不利影响。采购周期自中选结果实际执行之日起至2028年12月31日。</p><p>以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。</p></body></html>","source":"stockstar","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>广誉远最新公告：西黄丸和感冒清热颗粒中选全国中成药集采</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n广誉远最新公告：西黄丸和感冒清热颗粒中选全国中成药集采\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-18 17:42 北京时间&nbsp;&nbsp;&nbsp;<a href=https://stock.stockstar.com/RB2026061800031627.shtml><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>广誉远(600771.SH)公告称，公司控股子公司山西广誉远生产的西黄丸和感冒清热颗粒两款产品首次进入集采体系，且在本次全国中成药采购联盟集中带量采购中直接中选。上述产品2025年度及2026年第一季度销售收入极低，预计本次集采中选价格不会对公司现有存量业务的毛利率及当期利润产生重大不利影响。采购周期自中选结果实际执行之日起至2028年12月31日。以上内容为证券之星据公开信息整理，仅供参考不构成...</p>\n\n<a href=\"https://stock.stockstar.com/RB2026061800031627.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0188","symbol_name":"融资融券","start_time":0,"source_url":"https://stock.stockstar.com/RB2026061800031627.shtml","article_id":"2644079701","we_media_id":"1082532455","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2644079701","pubTimestamp":1781775740,"columns":[],"sourceInfo":{"source_id":"stockstar","name":"证券之星"},"weMediaInfo":{"media_name":"证券之星","introduction":"证券之星始创于1996年，是国内领先的金融信息及综合服务平台。关注证券之星，即时获取有价值的财经资讯。","home_visible":1,"id":"1082532455","head_image":"https://community-static.tradeup.com/news/2e305640fc27210243042d09d3a7fa3f"},"summary":"广誉远(600771.SH)公告称，公司控股子公司山西广誉远生产的西黄丸和感冒清热颗粒两款产品首次进入集采体系，且在本次全国中成药采购联盟集中带量采购中直接中选。上述产品2025年度及2026年第一季度销售收入极低，预计本次集采中选价格不会对公司现有存量业务的毛利率及当期利润产生重大不利影响。采购周期自中选结果实际执行之日起至2028年12月31日。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600771":"广誉远","BK0188":"融资融券","BK0077":"质押式回购","BK0239":"医药制造"},"translate_title":"Guangyuyuan's latest announcement: Xihuang Pill and Ganmao Qingre Granule were selected for national ready-for-use traditional Chinese medicine collection","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600771":1.5},"content_text":"广誉远(600771.SH)公告称，公司控股子公司山西广誉远生产的西黄丸和感冒清热颗粒两款产品首次进入集采体系，且在本次全国中成药采购联盟集中带量采购中直接中选。上述产品2025年度及2026年第一季度销售收入极低，预计本次集采中选价格不会对公司现有存量业务的毛利率及当期利润产生重大不利影响。采购周期自中选结果实际执行之日起至2028年12月31日。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2644079701","isCrawlerRequest":true}